A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study. (Q53527176)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study. |
scientific article |
Statements
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study. (English)
1 reference
Erin Cooney-Qualter
1 reference
Mark Krailo
1 reference
Anne Angiolillo
1 reference
Rashid A Fawwaz
1 reference
Gregory Wiseman
1 reference
Lauren Harrison
1 reference
Virginia Kohl
1 reference
Peter C Adamson
1 reference
Janet Ayello
1 reference
Carmella vande Ven
1 reference
Sherrie L Perkins
1 reference
Mitchell S Cairo
1 reference
Children's Oncology Group
1 reference
1 September 2007
1 reference
13
1 reference
18 Pt 2
1 reference
5652s-5660s
1 reference
Identifiers
1 reference